About DNTOX
DNTOX is a company based in Dusseldorf (Germany) founded in 2022 by Katharina Koch and Kristina Bartmann. DNTOX has raised $1.53 million across 1 funding round from investors including High-Tech Gründerfonds, Bool Capital and AQAL. DNTOX offers products and services including Developmental Neurotoxicity Testing and Adult Neurotoxicity Testing.
- Headquarter Dusseldorf, Germany
- Founders Katharina Koch, Kristina Bartmann
-
Sectors
Chemicals & Materials
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Dntox Gmbh
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$1.53 M (USD)
in 1 rounds
-
Latest Funding Round
$1.53 M (USD), Seed
Jun 19, 2023
-
Investors
High-Tech Gründerfonds
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of DNTOX
DNTOX offers a comprehensive portfolio of products and services, including Developmental Neurotoxicity Testing and Adult Neurotoxicity Testing.
Chemicals are evaluated for potential disturbances in brain development using multicellular and multiplexed human-based 2D/3D in vitro systems.
Compounds are assessed for neurotoxicity effects through 3D hiPSC-derived BrainSpheres on multi-electrode arrays to identify neurotransmitter receptor subtypes.
Funding Insights of DNTOX
DNTOX has successfully raised a total of $1.53M through 1 strategic funding round. The most recent funding activity was a Seed round of $1.53 million completed in June 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in DNTOX
DNTOX has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include High-Tech Gründerfonds, Bool Capital and AQAL.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage investments are made in high-tech startups by HTGF.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
AQAL is engaged in integral investing for sustainable prosperity.
|
Locked | Locked | Locked |
Investor details for DNTOX
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by DNTOX
Investment portfolio details for DNTOX
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - DNTOX
Detailed financials for DNTOX
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Dntox Comparisons
Peer comparison for DNTOX
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of DNTOX
Detailed competitors of DNTOX
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Dntox
Complete news archive for DNTOX
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about DNTOX
DNTOX was founded in 2022 and raised its 1st funding round 1 year after it was founded.
DNTOX is headquartered in Dusseldorf, Germany. It is registered at Dusseldorf, North Rhine-westphalia, Germany.
DNTOX is a funded company, having raised a total of $1.53M across 1 funding round to date.
DNTOX was founded in 2022 in Dusseldorf, Germany, by co-founders Katharina Koch and Kristina Bartmann. Operations focus on the chemical sector, where testing and development services are delivered to clients. The company maintains a presence through its domain dntox.de, supporting activities in chemical analysis and innovation within the European market. Services encompass various testing protocols and developmental processes tailored to industry needs.
DNTOX offers Developmental Neurotoxicity Testing and Adult Neurotoxicity Testing.
DNTOX has 3 investors. Key investors include High-Tech Gründerfonds, Bool Capital, and AQAL.